Already a member? Sign in
Category: Prescription Drugs
Generic Name: Alprazolam
See also: Xanax
Xanax XR® is a long-acting version of alprazolam, a benzodiazepine. It affects chemicals in the brain that may become unbalanced and cause anxiety. It is used to treat anxiety disorders, panic disorders, and anxiety caused by depression.
| Purpose | # of patients |
# of patients with evaluations
Efficacy
|
Major | Moderate | Slight | None | Can’t tell |
|---|---|---|---|---|---|---|---|
| Anxious mood | 36 | 11 |
|
|
|
||
| Panic attacks | 10 | 1 |
|
||||
| Insomnia | 7 | 2 |
|
|
|||
| Panic Disorder | 4 | 2 |
|
|
|||
| Other | 4 | 0 | |||||
| Treat my mood condition(s) | 4 | 1 |
|
See all 57 patients currently taking Xanax XR
Mouse over the table for more information
Commonly reported side effects, conditions, and hospitalizations associated with Xanax XR
| Drowsiness | 4 | |
|---|---|---|
| Sedation | 3 | |
| Excessive daytime sleepiness (somnolence) | 3 | |
| Problems concentrating | 2 | |
| Hangover effect | 1 | |
| Nausea | 1 | |
| See all 10 reported side effects ▼ | ||
Frequently reported dosages based on patients currently taking Xanax XR. See all 11 dosages ►
| Reason | # Patients | Percentage of patients | |
|---|---|---|---|
| Other | 8 | ||
| Doctor's advice | 7 | ||
| Did not seem to work | 3 | ||
| Course of treatment ended | 3 | ||
| Personal research | 1 | ||
| Side effects too severe | 1 | ||
| Expense | 1 |
Adherence
Taking treatment as prescribed
Adherence of Xanax XR
Always |
9 | 60% |
|
|---|---|---|---|
Usually |
1 | 7% |
|
Sometimes |
5 | 33% |
|
Never |
0 | 0% |
|
Burden
Difficulty being on treatment
Burden of Xanax XR
Very |
1 | 7% |
|
|---|---|---|---|
Somewhat |
0 | 0% |
|
A little |
2 | 13% |
|
Not at all |
12 | 80% |
|
Cost
Paid out of pocket
Cost of Xanax XR
$200+ |
0 | 0% |
|
|---|---|---|---|
$100-199 |
0 | 0% |
|
$50-99 |
1 | 9% |
|
$25-49 |
1 | 9% |
|
< $25 |
9 | 82% |
|
See more information, including instructions, precautions, side effects, and interactions.
Report created on May 26, 2012.